ORIENTBIO Inc. ((주)오리엔트바이오)
KOSPI Stock Code: 002630 | DART Corp Code: 00141626
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | ORIENTBIO Inc. |
|---|---|
| Korean legal name | (주)오리엔트바이오 |
| Alternate names | 오리엔트바이오 |
| Market | KOSPI |
| Stock Code | 002630 |
| DART Corp Code | 00141626 |
| CEO | 장재진 |
| Business Registration No. | 2188101142 |
| Corporate Registration No. | 1101110030116 |
| Established Date | 1959-04-16 |
| Fiscal Month | 03 |
| KSIC Industry Code | 212 |
| Address (KO) | 경기 성남시 중원구 상대원동 143-1 |
| Homepage | https://www.orientbio.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250619000265 |
| verified_at | 2026-11-01T02:19:21.549Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: OFS (Separate) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250619000265
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 29,397,883,042 | KRW 28,005,127,326 |
| Operating Income (영업이익) | KRW -3,076,404,782 | KRW -645,945,767 |
| Net Income (당기순이익) | KRW -13,194,865,821 | KRW 12,871,053,378 |
| Total Assets (자산총계) | KRW 84,781,838,689 | KRW 96,987,787,340 |
| Total Liabilities (부채총계) | KRW 12,935,042,105 | KRW 11,891,807,655 |
| Total Equity (자본총계) | KRW 71,846,796,584 | KRW 85,095,979,685 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-09-17 | 20260917000339 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 최숙종 |
2026-09-17 | 20260917000334 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 장재진 |
2026-09-17 | 20260917000326 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 오리엔트 |
2026-09-04 | 20260904000164 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 오리엔트 |
2026-09-04 | 20260904000129 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 오리엔트 |
2026-08-14 | 20260814002966 | Quarterly Report (2026.06) | 분기보고서 (2026.06) | 오리엔트바이오 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250619000265 | verified_at: 2026-11-01T02:19:21.549Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.